Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations

Area of Science:

• Endocrinology
• Oncology
• Cell Biology

Background:

• Islet cell tumors are neoplasms arising from pancreatic islet cells.
• These tumors can secrete various hormones, leading to distinct clinical syndromes.
• Understanding the molecular and secretory profiles of these tumors is crucial for diagnosis and management.

Purpose of the Study:

• To investigate the immunocytochemical and radioimmunoassay characteristics of islet cell tumors.
• To determine the presence and levels of pancreatic polypeptide (PP) and other hormones in these tumors.
• To evaluate the diagnostic potential of meal-stimulated PP secretion in patients with islet cell tumors.

Main Methods:

• Immunocytochemical staining was performed on tumor tissues.
• Radioimmunoassays were used to measure hormone concentrations in tissue extracts and plasma.
• Protein meal stimulation tests were conducted to assess PP secretion.

Main Results:

• All studied islet cell tumors were positive for neuron-specific enolase (NSE).
• Functioning tumors contained multiple pancreatic hormones; PP was a minor component in functioning tumors.
• Elevated plasma PP levels post-protein meal were observed in a significant percentage of patients with islet cell tumors.

Conclusions:

• Islet cell tumors originate from neuroendocrine cells expressing NSE.
• Pancreatic polypeptide is commonly present in functioning islet cell tumors.
• Meal-stimulated PP secretion can serve as a valuable biomarker for detecting functional islet cell tumors.